FLUORESCITE Side Effects

6951004-6 | Swollen Tongue, Urticaria
on Aug 11, 2010 Female patient from CANADA , 63 years of age, was treated with Fluorescite (View Usage). Patient experienced the following unwanted or unexpected effects: swollen tongue, urticaria. Fluorescite dosage: Intravenous Bolus. During the same period patient was treated with ATROPINE SULFATE (ATROPINE SULFATE) OPHTHALMIC (View Atropine Sulfate (atropine Sulfate) - Ophthalmic Review and Atropine Sulfate (atropine Sulfate) - Ophthalmic Label ).

6887582-5 | Blood Pressure Decreased, Eye Rolling, Loss Of Consciousness
Patient was taking Fluorescite (View Usage). Patient had the following side effects: blood pressure decreased, eye rolling, loss of consciousness on Jul 13, 2010 from JAPAN Additional patient health information: Male patient , 71 years of age, . Fluorescite dosage: 500 ,g = 5 Ml.

6861324-1 | Cough, Dyspnoea, Rash, Throat Tightness
Adverse event was reported on Jun 30, 2010 by a Male patient taking Fluorescite (View Usage) (Dosage: Intravenous Bolus) . Location: CANADA , 47 years of age, After Fluorescite was administered, patient had the following side effects: cough, dyspnoea, rash (What is rash?), throat tightness.

6861323-X | Abdominal Pain Upper, Paraesthesia, Pruritus
on Jun 30, 2010 Male patient from CANADA , 70 years of age, was treated with Fluorescite (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, paraesthesia, pruritus. Fluorescite dosage: Intravenous Bolus.


6861321-6 | Pruritus, Respiratory Arrest, Shock
on Jul 01, 2010 Male patient from JAPAN , 42 years of age, was diagnosed with angiogram retina and was treated with Fluorescite (View Usage). Patient had the following side effects: pruritus, respiratory arrest, shock. Fluorescite dosage: 500mg Iv Intravenous Bolus. Patient was hospitalized.

6814600-2 | Hyperhidrosis, Hypotension, Pallor, Syncope
Patient was taking Fluorescite (View Usage). After Fluorescite was administered, patient had the following side effects: hyperhidrosis, hypotension, pallor, syncope on Jun 14, 2010 from CANADA Additional patient health information: Male patient , 51 years of age, . Fluorescite dosage: 5 Ml 1x. During the same period patient was treated with METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), INSULIN (INSULIN) (View Insulin (insulin) Review and Insulin (insulin) Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

6786979-1 | Rash, Vasculitis
Adverse event was reported on Jun 09, 2010 by a Male patient taking Fluorescite (View Usage) (Dosage: 2 Ml/5 Seconds, Intraocular) was diagnosed with angiogram and. Location: JAPAN , 64 years of age, Patient experienced the following unwanted or unexpected effects: rash (What is rash?), vasculitis (What is vasculitis?). Patient was hospitalized.

6773647-5 | Erythema, Hypotension, Hypoventilation, Syncope
on May 28, 2010 Female patient from CZECH REPUBLIC , 82 years of age, was treated with Fluorescite (View Usage). Patient had the following side effects: erythema, hypotension, hypoventilation, syncope. Fluorescite dosage: Intraocular. During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ), VENELBIN (VENELBIN) (View Venelbin (venelbin) Review and Venelbin (venelbin) Label ), GODASAL (GODASAL) (View Godasal (godasal) Review and Godasal (godasal) Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), METFORMIN HYDROCHLORIDE (View Metformin Hydrochloride Review and Metformin Hydrochloride Label ). Patient was hospitalized.

6773646-3 | Rash, Vasculitis
on May 28, 2010 Male patient from JAPAN , 64 years of age, was diagnosed with angiogram and was treated with Fluorescite (View Usage). After Fluorescite was administered, patient had the following side effects: rash (What is rash?), vasculitis (What is vasculitis?). Fluorescite dosage: 2 Ml/5 Seconds Intraocular.

6773644-X | Erythema, Hypotension, Hypoventilation, Syncope
Patient was taking Fluorescite (View Usage). Patient experienced the following unwanted or unexpected effects: erythema, hypotension, hypoventilation, syncope on May 28, 2010 from CZECH REPUBLIC Additional patient health information: Female patient , 84 years of age, . Fluorescite dosage: Intraocular. During the same period patient was treated with COXTRAL (NIMESULIDE) (View Coxtral (nimesulide) Review and Coxtral (nimesulide) Label ), OXAZEPAM (View Oxazepam Review and Oxazepam Label ), GERATAM (PIRACETAM) (View Geratam (piracetam) Review and Geratam (piracetam) Label ), PILOCARPIN (PILOCARPINE HYDROCHLORIDE) (View Pilocarpin (pilocarpine Hydrochloride) Review and Pilocarpin (pilocarpine Hydrochloride) Label ), TIMOLOL MALEATE (View Timolol Maleate Review and Timolol Maleate Label ). Patient was hospitalized.

6691273-3 | Dizziness, Heart Rate Decreased, Hypotension, Malaise, Rash Macular, Sneezing, Syncope, Wheezing
Adverse event was reported on Mar 10, 2010 by a Female patient taking Fluorescite (View Usage) (Dosage: 5 Ml (1ml/sec) Intravenous Bolus) . Location: CANADA , 88 years of age, Patient had the following side effects: dizziness (What is dizziness?), heart rate decreased, hypotension, malaise, rash macular, sneezing, syncope, wheezing. During the same period patient was treated with ATENOLAL (ATENOLOL) (View Atenolal (atenolol) Review and Atenolal (atenolol) Label ), ATACAND (View Atacand Review and Atacand Label ). Patient was hospitalized.

6687414-4 | Anuria, Gastrointestinal Necrosis, Haematemesis, Loss Of Consciousness, Nausea, Necrosis Ischaemic, Oxygen Saturation Decreased, Pancreatic Disorder, Shock
on Apr 08, 2010 Male patient from JAPAN , 62 years of age, was diagnosed with diabetes mellitus and was treated with Fluorescite (View Usage). After Fluorescite was administered, patient had the following side effects: anuria, gastrointestinal necrosis, haematemesis, loss of consciousness, nausea (What is nausea?), necrosis ischaemic, oxygen saturation decreased, pancreatic disorder, shock. Fluorescite dosage: 500mg Iv X1 [1 Ml/sec] Intravenous Bolus. During the same period patient was treated with CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), ATELEC (CILNIDIPINE) (View Atelec (cilnidipine) Review and Atelec (cilnidipine) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PERSANTINE (View Persantine Review and Persantine Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), CRESTOR (View Crestor Review and Crestor Label ), BASEN (VOGLIBOSE) (View Basen (voglibose) Review and Basen (voglibose) Label ), AMARYL (View Amaryl Review and Amaryl Label ). Patient was hospitalized.

6662615-X | Dyspnoea, Injection Site Reaction, Skin Discolouration, Throat Irritation
on Mar 16, 2010 Male patient from POLAND , 17 years of age, was treated with Fluorescite (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, injection site reaction, skin discolouration, throat irritation. Fluorescite dosage: Intravenous Bolus.

6655305-0 | Gastrointestinal Necrosis, Haematemesis, Loss Of Consciousness, Nausea, Shock
Patient was taking Fluorescite (View Usage). Patient had the following side effects: gastrointestinal necrosis, haematemesis, loss of consciousness, nausea (What is nausea?), shock on Mar 10, 2010 from JAPAN Additional patient health information: Male patient , 62 years of age, was diagnosed with diabetes mellitus and. Fluorescite dosage: 500mg Iv X1 (1 Ml/sec Intravenous Bolus. During the same period patient was treated with CANDESARTAN CILEXETIL (View Candesartan Cilexetil Review and Candesartan Cilexetil Label ), ATELEC (CILNIDIPINE) (View Atelec (cilnidipine) Review and Atelec (cilnidipine) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PERSANTINE (View Persantine Review and Persantine Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), CRESTOR (View Crestor Review and Crestor Label ), BASEN (VOGLIBOSE) (View Basen (voglibose) Review and Basen (voglibose) Label ), AMARYL (View Amaryl Review and Amaryl Label ). Patient was hospitalized.

6615288-6 | Abdominal Pain, Hyperhidrosis, Malaise, Nausea, Syncope
Adverse event was reported on Feb 17, 2010 by a Male patient taking Fluorescite (View Usage) (Dosage: 1000 Mg Intravenous Bolus) was diagnosed with angiogram retina and. Location: NETHERLANDS , 70 years of age, After Fluorescite was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), hyperhidrosis, malaise, nausea (What is nausea?), syncope. During the same period patient was treated with MIXTARD (INSULIN HUMAN) (View Mixtard (insulin Human) Review and Mixtard (insulin Human) Label ), ASCAL (CARBASALATE CALCIUM) (View Ascal (carbasalate Calcium) Review and Ascal (carbasalate Calcium) Label ), METOPROLOLSUCCINAAT SANDOZ(METOPROLOL SUCCINATE) (View Metoprololsuccinaat Sandoz(metoprolol Succinate) Review and Metoprololsuccinaat Sandoz(metoprolol Succinate) Label ), ENALAPRILMALEAAT (ENALAPRIL MALEATE) (View Enalaprilmaleaat (enalapril Maleate) Review and Enalaprilmaleaat (enalapril Maleate) Label ), MYDRAISERT (MYDRIN P) (View Mydraisert (mydrin P) Review and Mydraisert (mydrin P) Label ). Patient was hospitalized.

6592730-0 | Anaphylactic Shock, Asthenia, Fatigue, Somnolence
on Jan 26, 2010 Female patient from GERMANY , 90 years of age, was treated with Fluorescite (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, asthenia, fatigue, somnolence. Fluorescite dosage: 4 Ml Intravenous Bolus. Patient was hospitalized.

6556598-0 | Blood Glucose Increased, Cardiovascular Disorder, Circulatory Collapse, Dizziness, Hyperhidrosis, Loss Of Consciousness, Palpitations, Respiratory Distress
on Jan 15, 2010 Female patient from GERMANY , 72 years of age, was diagnosed with angiogram retina and was treated with Fluorescite (View Usage). Patient had the following side effects: blood glucose increased, cardiovascular disorder, circulatory collapse, dizziness (What is dizziness?), hyperhidrosis, loss of consciousness, palpitations, respiratory distress. Fluorescite dosage: 3 Ml, Intravenous Bolus. During the same period patient was treated with BISOPROLOL (BISOPROLOL FUMARATE) (View Bisoprolol (bisoprolol Fumarate) Review and Bisoprolol (bisoprolol Fumarate) Label ). Patient was hospitalized.

6551146-3 | Acute Myocardial Infarction, Asthenia, Atrioventricular Block First Degree, Blood Potassium Decreased, Blood Urea Increased, Dyspnoea, Fatigue, Hyperhidrosis, Left Ventricular Dysfunction
Patient was taking Fluorescite (View Usage). After Fluorescite was administered, patient had the following side effects: acute myocardial infarction, asthenia, atrioventricular block first degree, blood potassium decreased, blood urea increased, dyspnoea, fatigue, hyperhidrosis, left ventricular dysfunction on Jan 07, 2010 from GERMANY Additional patient health information: Male patient , 72 years of age, was diagnosed with retinal vein occlusion and. Fluorescite dosage: 4 Ml, Intravenous Bolus. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), DOXAZOSIN (DOXAZOSIN MESILATE) (View Doxazosin (doxazosin Mesilate) Review and Doxazosin (doxazosin Mesilate) Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), CORIFEO (LERCANIDIPINE HYDROCHLORIDE) (View Corifeo (lercanidipine Hydrochloride) Review and Corifeo (lercanidipine Hydrochloride) Label ). Patient was hospitalized.

6538212-3 | Blood Pressure Decreased, Dizziness, Fall, Flushing, Loss Of Consciousness
Adverse event was reported on Dec 28, 2009 by a Male patient taking Fluorescite (View Usage) (Dosage: Intravenous Bolus) . Location: GERMANY , 67 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure decreased, dizziness (What is dizziness?), fall (What is fall?), flushing, loss of consciousness. During the same period patient was treated with HUMALOG (View Humalog Review and Humalog Label ), INSULIN B (INSULIN HUMAN) (View Insulin B (insulin Human) Review and Insulin B (insulin Human) Label ), ESPA LIPON (THIOCTIC ACID) (View Espa Lipon (thioctic Acid) Review and Espa Lipon (thioctic Acid) Label ), SIMVABETA (SIMVASTATIN) (View Simvabeta (simvastatin) Review and Simvabeta (simvastatin) Label ), BISOPROLOL CT (BISOPROLOL FUMARATE) (View Bisoprolol Ct (bisoprolol Fumarate) Review and Bisoprolol Ct (bisoprolol Fumarate) Label ), ALPHAGAN (BRIMONIDINE) (View Alphagan (brimonidine) Review and Alphagan (brimonidine) Label ), TRAVATAN (View Travatan Review and Travatan Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ).

6538192-0 | Acute Myocardial Infarction, Asthenia, Atrioventricular Block First Degree, Chest Discomfort, Fatigue, Hyperhidrosis, Nausea, Rectal Tenesmus
on Dec 28, 2009 Male patient from GERMANY , 72 years of age, was diagnosed with venous occlusion and was treated with Fluorescite (View Usage). Patient had the following side effects: acute myocardial infarction, asthenia, atrioventricular block first degree, chest discomfort, fatigue, hyperhidrosis, nausea (What is nausea?), rectal tenesmus. Fluorescite dosage: 4 Ml Intravenous Bolus. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), DOXAZOSIN (DOXAZOSIN MESILATE) (View Doxazosin (doxazosin Mesilate) Review and Doxazosin (doxazosin Mesilate) Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), CORIFEO (LERCANIDIPINE HYDROCHLORIDE) (View Corifeo (lercanidipine Hydrochloride) Review and Corifeo (lercanidipine Hydrochloride) Label ). Patient was hospitalized.

6538049-5 | Asthenia, Circulatory Collapse, Dizziness, Dyspnoea, Fatigue, Hyperhidrosis, Loss Of Consciousness, Palpitations, Respiratory Distress
on Dec 28, 2009 Female patient from GERMANY , 72 years of age, was diagnosed with angiogram retina and was treated with Fluorescite (View Usage). After Fluorescite was administered, patient had the following side effects: asthenia, circulatory collapse, dizziness (What is dizziness?), dyspnoea, fatigue, hyperhidrosis, loss of consciousness, palpitations, respiratory distress. Fluorescite dosage: 3 Ml Intravenous Bolus. During the same period patient was treated with BISOPROLOL (BISOPROLOL FUMARATE) (View Bisoprolol (bisoprolol Fumarate) Review and Bisoprolol (bisoprolol Fumarate) Label ). Patient was hospitalized.

6537400-X | Hallucination, Hypersomnia
Patient was taking Fluorescite (View Usage). Patient experienced the following unwanted or unexpected effects: hallucination, hypersomnia on Dec 23, 2009 from GERMANY Additional patient health information: Female patient , 83 years of age, was diagnosed with angiogram retina and. Fluorescite dosage: 5 Ml (0.16ml/s) Intravenous Bolus.

6537398-4 | Asthenia, Cerebrovascular Accident, Fall
Adverse event was reported on Dec 23, 2009 by a Female patient taking Fluorescite (View Usage) (Dosage: 5 Ml (0.17 Ml/s) Intravenous Bolus) was diagnosed with angiogram retina and. Location: GERMANY , 61 years of age, Patient had the following side effects: asthenia, cerebrovascular accident, fall (What is fall?). During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ). Patient was hospitalized and became disabled.

6529126-3 | Atrioventricular Block First Degree, Myocardial Infarction
on Dec 21, 2009 Male patient from GERMANY , 72 years of age, was diagnosed with venous occlusion and was treated with Fluorescite (View Usage). After Fluorescite was administered, patient had the following side effects: atrioventricular block first degree, myocardial infarction. Fluorescite dosage: 4 Ml Intravenous Bolus. During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), DOXAZOSIN (DOXAZOSIN MESILATE) (View Doxazosin (doxazosin Mesilate) Review and Doxazosin (doxazosin Mesilate) Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), CORIFEO (LERCANIDIPINE HYDROCHLORIDE) (View Corifeo (lercanidipine Hydrochloride) Review and Corifeo (lercanidipine Hydrochloride) Label ). Patient was hospitalized.

6529125-1 | Blood Pressure Decreased, Dizziness, Erythema, Flushing, Loss Of Consciousness
on Dec 21, 2009 Male patient from GERMANY , 67 years of age, was treated with Fluorescite (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, dizziness (What is dizziness?), erythema, flushing, loss of consciousness. Fluorescite dosage: Intravenous Bolus. During the same period patient was treated with HUMALOG (View Humalog Review and Humalog Label ), INSULIN B BRAUN RATIOPHARM (INSULIN HUMAN) (View Insulin B Braun Ratiopharm (insulin Human) Review and Insulin B Braun Ratiopharm (insulin Human) Label ), ESPA LIPON (THIOCTIC ACID) (View Espa Lipon (thioctic Acid) Review and Espa Lipon (thioctic Acid) Label ), SIMVABETA (SIMVASTATIN) (View Simvabeta (simvastatin) Review and Simvabeta (simvastatin) Label ), BISOPROLOL CT (BISOPROLOL FUMARATE) (View Bisoprolol Ct (bisoprolol Fumarate) Review and Bisoprolol Ct (bisoprolol Fumarate) Label ), ALPHAGAN (BRIMONIDINE) (View Alphagan (brimonidine) Review and Alphagan (brimonidine) Label ), TRAVATAN (View Travatan Review and Travatan Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ).

6523166-6 | Blood Pressure Decreased, Dizziness, Flushing, Loss Of Consciousness
Patient was taking Fluorescite (View Usage). Patient had the following side effects: blood pressure decreased, dizziness (What is dizziness?), flushing, loss of consciousness on Dec 16, 2009 from GERMANY Additional patient health information: Male patient , 67 years of age, . Fluorescite dosage: Intravenous Bolus. During the same period patient was treated with HUMALOG (View Humalog Review and Humalog Label ), INSULIN B BRAUN RATIOPHARM(INSULIN HUMAN) (View Insulin B Braun Ratiopharm(insulin Human) Review and Insulin B Braun Ratiopharm(insulin Human) Label ), ESPA LIPON(THIOCTIC ACID) (View Espa Lipon(thioctic Acid) Review and Espa Lipon(thioctic Acid) Label ), SIMVABETA (SIMVASTATIN) (View Simvabeta (simvastatin) Review and Simvabeta (simvastatin) Label ), BISOPROLOL CT (BISOPROLOL FUMARATE) (View Bisoprolol Ct (bisoprolol Fumarate) Review and Bisoprolol Ct (bisoprolol Fumarate) Label ), ALPHAGAN (BRIMONIDINE) (View Alphagan (brimonidine) Review and Alphagan (brimonidine) Label ), TRAVATAN (View Travatan Review and Travatan Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ).

6523153-8 | Asthenia, Blood Pressure Decreased, Circulatory Collapse, Dizziness, Fatigue, Heart Rate Decreased, Hyperhidrosis, Loss Of Consciousness, Palpitations
Adverse event was reported on Dec 16, 2009 by a Male patient taking Fluorescite (View Usage) (Dosage: 5 Ml Intravenous Bolus) was diagnosed with angiogram retina and. Location: GERMANY , 61 years of age, After Fluorescite was administered, patient had the following side effects: asthenia, blood pressure decreased, circulatory collapse, dizziness (What is dizziness?), fatigue, heart rate decreased, hyperhidrosis, loss of consciousness, palpitations. During the same period patient was treated with METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ).

6523152-6 | Atrioventricular Block First Degree, Myocardial Infarction, Rectal Tenesmus
on Dec 15, 2009 Male patient from GERMANY , 72 years of age, was diagnosed with venous occlusion and was treated with Fluorescite (View Usage). Patient experienced the following unwanted or unexpected effects: atrioventricular block first degree, myocardial infarction, rectal tenesmus. Fluorescite dosage: 5 Ml, Intravenous Bolus. Patient was hospitalized.

6523151-4 | Asthenia, Cardiac Arrest, Dizziness, Fatigue, Hyperhidrosis, Syncope
on Dec 11, 2009 Male patient from GERMANY , 74 years of age, was treated with Fluorescite (View Usage). Patient had the following side effects: asthenia, cardiac arrest (What is cardiac arrest?), dizziness (What is dizziness?), fatigue, hyperhidrosis, syncope. Fluorescite dosage: 5 Ml, Intravenous Bolus. During the same period patient was treated with METFORMIN HCL (850mg Bid) (View Metformin Hcl Review and Metformin Hcl Label ), GLIMEPIRID (GLIMIPIRIDE) (850mg Bid) (View Glimepirid (glimipiride) Review and Glimepirid (glimipiride) Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ).

6523100-9 | Anaphylactic Shock, Atrial Fibrillation, Brain Oedema, Cerebral Infarction, Haematoma, Loss Of Consciousness
Patient was taking Fluorescite (View Usage). After Fluorescite was administered, patient had the following side effects: anaphylactic shock, atrial fibrillation (What is atrial fibrillation?), brain oedema, cerebral infarction, haematoma, loss of consciousness on Dec 17, 2009 from JAPAN Additional patient health information: Female patient , 70 years of age, was diagnosed with diabetic retinopathy and. Fluorescite dosage: 3 Ml. During the same period patient was treated with SANCOBA (CYANOCOBALAMIN) (View Sancoba (cyanocobalamin) Review and Sancoba (cyanocobalamin) Label ), PENFILL 30R(HUMAN MIXTARD) (View Penfill 30r(human Mixtard) Review and Penfill 30r(human Mixtard) Label ), DIOVAN (View Diovan Review and Diovan Label ). Patient was hospitalized.

6523095-8 | Abdominal Pain Upper, Activated Partial Thromboplastin Time Prolonged, Blood Cholesterol Increased, Blood Glucose Increased, Blood Pressure Decreased, Blood Thyroid Stimulating Hormone Decreased, Haematoma, Haemoglobin Decreased
Adverse event was reported on Dec 08, 2009 by a Female patient taking Fluorescite (View Usage) (Dosage: 5 Ml (1.6 Ml/sec)) was diagnosed with retinal vein occlusion and. Location: GERMANY , 83 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain upper, activated partial thromboplastin time prolonged, blood cholesterol increased, blood glucose increased, blood pressure decreased, blood thyroid stimulating hormone decreased, haematoma, haemoglobin decreased. During the same period patient was treated with AMITRIPTYLINE AND PSYCHOLEPTICS (AMITRIPTYLINE AND PSYCHOLEPTICS) (View Amitriptyline And Psycholeptics (amitriptyline And Psycholeptics) Review and Amitriptyline And Psycholeptics (amitriptyline And Psycholeptics) Label ), CALCIGEN D(LEKOVIT CA) (View Calcigen D(lekovit Ca) Review and Calcigen D(lekovit Ca) Label ), DICLOFENAC (DICLOFENAC DIETHYLAMINE) (View Diclofenac (diclofenac Diethylamine) Review and Diclofenac (diclofenac Diethylamine) Label ), ISOSORBIDE DINITRATE (View Isosorbide Dinitrate Review and Isosorbide Dinitrate Label ), METFORMIN HEXAL (METFORMIN HYDROCHLORIDE) (View Metformin Hexal (metformin Hydrochloride) Review and Metformin Hexal (metformin Hydrochloride) Label ), METOHEXAL SUCC (METOPROLOL SUCCINATE) (View Metohexal Succ (metoprolol Succinate) Review and Metohexal Succ (metoprolol Succinate) Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), RANITIDIN (RANITIDINE HYDRROCHLORIDE) (View Ranitidin (ranitidine Hydrrochloride) Review and Ranitidin (ranitidine Hydrrochloride) Label ). Patient was hospitalized.

6509513-X | Asthenia, Blood Glucose Increased, Blood Pressure Diastolic Decreased, Cardiac Arrest, Convulsion, Fall, Fatigue, Hyperhidrosis, Loss Of Consciousness
on Dec 02, 2009 Female patient from GERMANY , 74 years of age, was diagnosed with diabetic retinopathy and was treated with Fluorescite (View Usage). Patient had the following side effects: asthenia, blood glucose increased, blood pressure diastolic decreased, cardiac arrest (What is cardiac arrest?), convulsion, fall (What is fall?), fatigue, hyperhidrosis, loss of consciousness. Fluorescite dosage: 5 Ml. During the same period patient was treated with L THYROX (LEVOTHYROXINE SODIUM) (View L-thyrox (levothyroxine Sodium) Review and L-thyrox (levothyroxine Sodium) Label ), OXAZEPAM (View Oxazepam Review and Oxazepam Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), LANTUS (View Lantus Review and Lantus Label ), THIORIDAZINE HCL (View Thioridazine Hcl Review and Thioridazine Hcl Label ), VOLTAREN (View Voltaren Review and Voltaren Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ).

6505092-1 | Arrhythmia, Asthenia, Blood Lactate Dehydrogenase Increased, Blood Pressure Decreased, Blood Pressure Immeasurable, Chest Pain, Cold Sweat, Dizziness, Fatigue
on Dec 01, 2009 Male patient from GERMANY , 60 years of age, was treated with Fluorescite (View Usage). After Fluorescite was administered, patient had the following side effects: arrhythmia (What is arrhythmia?), asthenia, blood lactate dehydrogenase increased, blood pressure decreased, blood pressure immeasurable, chest pain (What is chest pain?), cold sweat, dizziness (What is dizziness?), fatigue. Fluorescite dosage: 2.5 Ml.

6505091-X | Cold Sweat, Hypersensitivity, Hypoglycaemia, Incontinence, Muscle Spasms, Nausea, Syncope, Unresponsive To Stimuli
Patient was taking Fluorescite (View Usage). Patient experienced the following unwanted or unexpected effects: cold sweat, hypersensitivity, hypoglycaemia, incontinence, muscle spasms, nausea (What is nausea?), syncope, unresponsive to stimuli on Dec 04, 2009 from GERMANY Additional patient health information: Male patient , 69 years of age, . Fluorescite dosage: 5 Ml [1 Ml/sec] Iv Once. Patient was hospitalized.

6504044-5 | Hypotension
Adverse event was reported on Nov 30, 2009 by a Female patient taking Fluorescite (View Usage) (Dosage: 5 Ml 1x, 5 Ml Iv At 1 Ml/sec Intravenous Bolus) was diagnosed with diabetic retinopathy and. Location: GERMANY , 51 years of age, Patient had the following side effects: hypotension.

6497567-9 | Anaphylactic Shock, Chest Pain, Contusion, Dyspnoea, Loss Of Consciousness, Resuscitation
on Nov 25, 2009 Male patient from GERMANY , 71 years of age, was diagnosed with angiogram retina and was treated with Fluorescite (View Usage). After Fluorescite was administered, patient had the following side effects: anaphylactic shock, chest pain (What is chest pain?), contusion, dyspnoea, loss of consciousness, resuscitation. Fluorescite dosage: 5 Ml 93-5 Seconds), Intravenous Bolus. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), SALBUHEXAL (SALBUTAMOL) (View Salbuhexal (salbutamol) Review and Salbuhexal (salbutamol) Label ). Patient was hospitalized.

6497542-4 | Blood Pressure Decreased, Cold Sweat, Loss Of Consciousness, Syncope, Unresponsive To Stimuli
on Nov 26, 2009 Female patient from GERMANY , 73 years of age, was treated with Fluorescite (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure decreased, cold sweat, loss of consciousness, syncope, unresponsive to stimuli. Fluorescite dosage: 2.5 Ml, Intravenous Bolus. During the same period patient was treated with RASILEZ (ALISKIREN) (View Rasilez (aliskiren) Review and Rasilez (aliskiren) Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), TALOHEXAL (CITALOPRAM HYDROBROMIDE) (View Talohexal (citalopram Hydrobromide) Review and Talohexal (citalopram Hydrobromide) Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), SAROTEN RET (View Saroten Ret Review and Saroten Ret Label ), PANTOPRAZOL (View Pantoprazol Review and Pantoprazol Label ), ALPRENOLOL TEVA (View Alprenolol Teva Review and Alprenolol Teva Label ).

6497540-0 | Anaphylactic Shock, Atrial Fibrillation, Cerebellar Infarction, Haematoma, Heart Rate Decreased
Patient was taking Fluorescite (View Usage). Patient had the following side effects: anaphylactic shock, atrial fibrillation (What is atrial fibrillation?), cerebellar infarction, haematoma, heart rate decreased on Nov 26, 2009 from JAPAN Additional patient health information: Female patient , 70 years of age, . Fluorescite dosage: 3 Ml Intravenous Bolus. During the same period patient was treated with SANCOBA (CYANOCOBALAMIN) (View Sancoba (cyanocobalamin) Review and Sancoba (cyanocobalamin) Label ), PENFILL 30R (HUMAN MIXTARD) (View Penfill 30r (human Mixtard) Review and Penfill 30r (human Mixtard) Label ), DIOVAN (View Diovan Review and Diovan Label ). Patient was hospitalized.

6491615-8 | Acute Myocardial Infarction, Asthenia, Blood Pressure Decreased, Coronary Artery Occlusion, Coronary Artery Stenosis, Dizziness, Electrocardiogram St Segment Elevation, Fatigue, Heart Rate Decreased
Adverse event was reported on Nov 23, 2009 by a Female patient taking Fluorescite (View Usage) (Dosage: 3.5 Ml, Intravenous Bolus) . Location: GERMANY , 81 years of age, After Fluorescite was administered, patient had the following side effects: acute myocardial infarction, asthenia, blood pressure decreased, coronary artery occlusion, coronary artery stenosis, dizziness (What is dizziness?), electrocardiogram st segment elevation, fatigue, heart rate decreased. During the same period patient was treated with BISOPROLOL (BISOPROLOL FUMARATE) (View Bisoprolol (bisoprolol Fumarate) Review and Bisoprolol (bisoprolol Fumarate) Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), NEBIVOLOL HCL (View Nebivolol Hcl Review and Nebivolol Hcl Label ). Patient was hospitalized.

6474811-5 | Aortic Aneurysm, Aortic Valve Disease, Bile Duct Stone, Blood Cholesterol Increased, Blood Homocysteine Increased, Blood Pressure Increased, Cholelithiasis, Choroidal Detachment, Coronary Artery Disease
on Nov 12, 2009 Male patient from GERMANY , 89 years of age, was treated with Fluorescite (View Usage). Patient experienced the following unwanted or unexpected effects: aortic aneurysm (What is aortic aneurysm?), aortic valve disease, bile duct stone, blood cholesterol increased, blood homocysteine increased, blood pressure increased, cholelithiasis, choroidal detachment, coronary artery disease (What is coronary artery disease?). Fluorescite dosage: 5 Ml Iv Over 25 Sec Intravenous Bolus. During the same period patient was treated with RAMIPRIL (View Ramipril Review and Ramipril Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6474807-3 | Hypotension
on Nov 20, 2009 Female patient from GERMANY , 51 years of age, was treated with Fluorescite (View Usage). Patient had the following side effects: hypotension. Fluorescite dosage: 5 Ml 1x 5 Ml Iv At 1 Ml/sec.

6472866-5 | Blood Pressure Decreased, Heart Rate Decreased, Hypersensitivity, Syncope, Vomiting
Patient was taking Fluorescite (View Usage). After Fluorescite was administered, patient had the following side effects: blood pressure decreased, heart rate decreased, hypersensitivity, syncope, vomiting on Nov 24, 2009 from GERMANY Additional patient health information: Female patient , 74 years of age, . Fluorescite dosage: 4 Ml Intravenous Bolus. During the same period patient was treated with AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), MARCUMAR (View Marcumar Review and Marcumar Label ).

6461209-9 | Blood Pressure Decreased, Circulatory Collapse, Heart Rate Decreased, Loss Of Consciousness, Retrograde Amnesia
Adverse event was reported on Nov 17, 2009 by a Male patient taking Fluorescite (View Usage) (Dosage: Intravenous Bolus) . Location: GERMANY , 61 years of age, Patient experienced the following unwanted or unexpected effects: blood pressure decreased, circulatory collapse, heart rate decreased, loss of consciousness, retrograde amnesia. During the same period patient was treated with METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), LERCANIDIPINE (View Lercanidipine Review and Lercanidipine Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), ALOPURINOL(ALLOPURINOL) (View Alopurinol(allopurinol) Review and Alopurinol(allopurinol) Label ).

6454683-5 | Myocardial Infarction
on Nov 04, 2009 Female patient from GERMANY , 81 years of age, was treated with Fluorescite (View Usage). Patient had the following side effects: myocardial infarction. Fluorescite dosage: 3.5 Ml, Intravenous Bolus. During the same period patient was treated with BISOPROLOL (BISOPROLOL FUMARATE) (View Bisoprolol (bisoprolol Fumarate) Review and Bisoprolol (bisoprolol Fumarate) Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

6454682-3 | Blood Pressure Decreased, Blood Pressure Increased, Circulatory Collapse, Dyspnoea, Nausea, Tachycardia
on Nov 04, 2009 Female patient from GERMANY , 71 years of age, was treated with Fluorescite (View Usage). After Fluorescite was administered, patient had the following side effects: blood pressure decreased, blood pressure increased, circulatory collapse, dyspnoea, nausea (What is nausea?), tachycardia. Fluorescite dosage: 2.5 Ml 0.5ml/sec, Intravenous Bolus.

6454681-1 | Bradycardia, Cold Sweat, Facial Paresis, Fall, Heart Rate Increased, Hypotension, Immediate Post-injection Reaction, Loss Of Consciousness, Mydriasis
Patient was taking Fluorescite (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, cold sweat, facial paresis, fall (What is fall?), heart rate increased, hypotension, immediate post-injection reaction, loss of consciousness, mydriasis on Nov 04, 2009 from GERMANY Additional patient health information: Male patient , 86 years of age, . Fluorescite dosage: 2.5 Ml, Intravenous Bolus. During the same period patient was treated with METOPROLOL (METOPROLOL) (View Metoprolol (metoprolol) Review and Metoprolol (metoprolol) Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), MOLSIDOMIN (MOLSIDOMINE) (View Molsidomin (molsidomine) Review and Molsidomin (molsidomine) Label ), BEZAFIBRATE (BEZAFIBRATE) (View Bezafibrate (bezafibrate) Review and Bezafibrate (bezafibrate) Label ), PRONTOPYRIN (PRONTOPYRIN) (View Prontopyrin (prontopyrin) Review and Prontopyrin (prontopyrin) Label ), NOVALGIN (METAMIZOLE SODIUM) (View Novalgin (metamizole Sodium) Review and Novalgin (metamizole Sodium) Label ), HCT GAMMA (HYDROCHLOROTHIAZIDE) (View Hct Gamma (hydrochlorothiazide) Review and Hct Gamma (hydrochlorothiazide) Label ), TRAMADOL HCL (View Tramadol Hcl Review and Tramadol Hcl Label ).

6454680-X | Circulatory Collapse, Myocardial Infarction, Post Procedural Complication
Adverse event was reported on Nov 05, 2009 by a Male patient taking Fluorescite (View Usage) (Dosage: 2.5 Ml, Intravenous Bolus) was diagnosed with angiogram retina and. Location: GERMANY , 78 years of age, Patient had the following side effects: circulatory collapse, myocardial infarction, post procedural complication. During the same period patient was treated with NITRENDIPINO RATIOPHARM (NITRENDIPINE) (View Nitrendipino Ratiopharm (nitrendipine) Review and Nitrendipino Ratiopharm (nitrendipine) Label ), L THYROXIN BETA (LEVOTHYROXINE SODIUM) (View L-thyroxin Beta (levothyroxine Sodium) Review and L-thyroxin Beta (levothyroxine Sodium) Label ), LISINOPRIL RATIOPHARM (LISINOPRIL) (View Lisinopril Ratiopharm (lisinopril) Review and Lisinopril Ratiopharm (lisinopril) Label ), UROXATRAL (View Uroxatral Review and Uroxatral Label ).

6442330-8 | Dyspnoea, Nausea, Palpitations, Presyncope
on Oct 27, 2009 Female patient from CZECH REPUBLIC , 52 years of age, was diagnosed with angiogram and was treated with Fluorescite (View Usage). After Fluorescite was administered, patient had the following side effects: dyspnoea, nausea (What is nausea?), palpitations, presyncope. Fluorescite dosage: 5 Ml, Intravenous Bolus. During the same period patient was treated with DITHIADEN (BISULEPIN HYDROCHLORIDE) (View Dithiaden (bisulepin Hydrochloride) Review and Dithiaden (bisulepin Hydrochloride) Label ).

6442329-1 | Circulatory Collapse, Dyspnoea, Immediate Post-injection Reaction, Nausea
on Oct 27, 2009 Female patient from CZECH REPUBLIC , 69 years of age, was diagnosed with angiogram and was treated with Fluorescite (View Usage). Patient experienced the following unwanted or unexpected effects: circulatory collapse, dyspnoea, immediate post-injection reaction, nausea (What is nausea?). Fluorescite dosage: 5 Ml, Intravenous Bolus. During the same period patient was treated with DITHIADEN (BISULEPIN HYDROCHLORIDE) (View Dithiaden (bisulepin Hydrochloride) Review and Dithiaden (bisulepin Hydrochloride) Label ).

6442328-X | Acute Left Ventricular Failure, Acute Pulmonary Oedema, Blood Pressure Decreased, Cardiovascular Disorder, Hypotonia, Nausea, Pulmonary Congestion
Patient was taking Fluorescite (View Usage). Patient had the following side effects: acute left ventricular failure, acute pulmonary oedema, blood pressure decreased, cardiovascular disorder, hypotonia, nausea (What is nausea?), pulmonary congestion on Oct 27, 2009 from GERMANY Additional patient health information: Female patient , 90 years of age, was diagnosed with angiogram and. Fluorescite dosage: Intravenous Blous.